Search for "azides" in Full Text gives 211 result(s) in Beilstein Journal of Organic Chemistry. Showing first 200.
Beilstein J. Org. Chem. 2019, 15, 1722–1757, doi:10.3762/bjoc.15.168
Graphical Abstract
Figure 1: Examples of three-carbon chirons.
Figure 2: Structures of derivatives of N-(1-phenylethyl)aziridine-2-carboxylic acid 5–8.
Figure 3: Synthetic equivalency of aziridine aldehydes 6.
Scheme 1: Synthesis of N-(1-phenylethyl)aziridine-2-carboxylates 5. Reagents and conditions: a) TEA, toluene,...
Scheme 2: Absolute configuration at C2 in (2S,1'S)-5a. Reagents and conditions: a) 20% HClO4, 80 °C, 30 h the...
Scheme 3: Major synthetic strategies for a 2-ketoaziridine scaffold [R* = (R)- or (S)-1-phenylethyl; R′ = Alk...
Scheme 4: Synthesis of cyanide (2S,1'S)-13. Reagents and conditions: a) NH3, EtOH/H2O, rt, 72 h; b) Ph3P, CCl4...
Scheme 5: Synthesis of key intermediates (R)-16 and (R)-17 for (R,R)-formoterol (14) and (R)-tamsulosin (15)....
Scheme 6: Synthesis of mitotic kinesin inhibitors (2R/S,1'R)-23. Reagents and conditions: a) H2, Pd(OH)2, EtO...
Scheme 7: Synthesis of (R)-mexiletine ((R)-24). Reagents and conditions: a) TsCl, TEA, DMAP, CH2Cl2, rt, 1 h;...
Scheme 8: Synthesis of (−)-cathinone ((S)-27). Reagents and conditions: a) PhMgBr, ether, 0 °C; b) H2, 10% Pd...
Scheme 9: Synthesis of N-Boc-norpseudoephedrine ((1S,2S)-(+)-29) and N-Boc-norephedrine ((1R,2S)-29). Reagent...
Scheme 10: Synthesis of (−)-ephedrine ((1R,2S)-31). Reagents and conditions: a) TfOMe, MeCN then NaBH3CN, rt; ...
Scheme 11: Synthesis of xestoaminol C ((2S,3R)-35), 3-epi-xestoaminol C ((2S,3S)-35) and N-Boc-spisulosine ((2S...
Scheme 12: Synthesis of ʟ-tryptophanol ((S)-41). Reagents and conditions: a) CDI, MeCN, rt, 1 h then TMSI, MeC...
Scheme 13: Synthesis of ʟ-homophenylalaninol ((S)-42). Reagents and conditions: a) NaH, THF, 0 °C to −78 °C, 1...
Scheme 14: Synthesis of ᴅ-homo(4-octylphenyl)alaninol ((R)-47) and a sphingolipid analogue (R)-48. Reagents an...
Scheme 15: Synthesis of florfenicol ((1R,2S)-49). Reagents and conditions: a) (S)-1-phenylethylamine, TEA, MeO...
Scheme 16: Synthesis of natural tyroscherin ((2S,3R,6E,8R,10R)-55). Reagents and conditions: a) I(CH2)3OTIPS, t...
Scheme 17: Syntheses of (−)-hygrine (S)-61, (−)-hygroline (2S,2'S)-62 and (−)-pseudohygroline (2S,2'R)-62. Rea...
Scheme 18: Synthesis of pyrrolidine (3S,3'R)-68, a fragment of the fluoroquinolone antibiotic PF-00951966. Rea...
Scheme 19: Synthesis of sphingolipid analogues (R)-76. Reagents and conditions: a) BnBr, Mg, THF, reflux, 6 h;...
Scheme 20: Synthesis of ᴅ-threo-PDMP (1R,2R)-81. Reagents and conditions: a) TMSCl, NaI, MeCN, rt, 1 h 50 min,...
Scheme 21: Synthesis of the sphingolipid analogue SG-14 (2S,3S)-84. Reagents and conditions: a) LiAlH4, THF, 0...
Scheme 22: Synthesis of the sphingolipid analogue SG-12 (2S,3R)-88. Reagents and conditions: a) 1-(bromomethyl...
Scheme 23: Synthesis of sphingosine-1-phosphate analogues DS-SG-44 and DS-SG-45 (2S,3R)-89a and (2S,3R)-89a. R...
Scheme 24: Synthesis of N-Boc-safingol ((2S,3S)-95) and N-Boc-ᴅ-erythro-sphinganine ((2S,3R)-95). Reagents and...
Scheme 25: Synthesis of ceramide analogues (2S,3R)-96. Reagents and conditions: a) NaBH4, ZnCl2, MeOH, −78 °C,...
Scheme 26: Synthesis of orthogonally protected serinols, (S)-101 and (R)-102. Reagents and conditions: a) BnBr...
Scheme 27: Synthesis of N-acetyl-3-phenylserinol ((1R,2R)-105). Reagents and conditions: a) AcOH, CH2Cl2, refl...
Scheme 28: Synthesis of (S)-linezolid (S)-107. Reagents and conditions: a) LiAlH4, THF, 0 °C to reflux; b) Boc2...
Scheme 29: Synthesis of (2S,3S,4R)-2-aminooctadecane-1,3,4-triol (ᴅ-ribo-phytosphingosine) (2S,3S,4R)-110. Rea...
Scheme 30: Syntheses of ᴅ-phenylalanine (R)-116. Reagents and conditions: a) AcOH, CH2Cl2, reflux, 4 h; b) MsC...
Scheme 31: Synthesis of N-Boc-ᴅ-3,3-diphenylalanine ((R)-122). Reagents and conditions: a) PhMgBr, THF, −78 °C...
Scheme 32: Synthesis of ethyl N,N’-di-Boc-ʟ-2,3-diaminopropanoate ((S)-125). Reagents and conditions: a) NaN3,...
Scheme 33: Synthesis of the bicyclic amino acid (S)-(+)-127. Reagents and conditions: a) BF3·OEt2, THF, 60 °C,...
Scheme 34: Synthesis of lacosamide, (R)-2-acetamido-N-benzyl-3-methoxypropanamide (R)-130. Reagents and condit...
Scheme 35: Synthesis of N-Boc-norfuranomycin ((2S,2'R)-133). Reagents and conditions: a) H2C=CHCH2I, NaH, THF,...
Scheme 36: Synthesis of MeBmt (2S,3R,4R,6E)-139. Reagents and conditions: a) diisopropyl (S,S)-tartrate (E)-cr...
Scheme 37: Synthesis of (+)-polyoxamic acid (2S,3S,4S)-144. Reagents and conditions: a) AD-mix-α, MeSO2NH2, t-...
Scheme 38: Synthesis of the protected 3-hydroxy-ʟ-glutamic acid (2S,3R)-148. Reagents and conditions: a) LiHMD...
Scheme 39: Synthesis of (+)-isoserine (R)-152. Reagents and conditions: a) AcCl, MeCN, rt, 0.5 h then Na2CO3, ...
Scheme 40: Synthesis of (3R,4S)-N3-Boc-3,4-diaminopentanoic acid (3R,4S)-155. Reagents and conditions: a) Ph3P...
Scheme 41: Synthesis of methyl (2S,3S,4S)-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanoate (2S,3S,4S)-159. ...
Scheme 42: Syntheses of methyl (3S,4S) 4,5-di-N-Boc-amino-3-hydroxypentanoate ((3S,4S)-164), methyl (3S,4S)-4-N...
Scheme 43: Syntheses of (3R,5S)-5-(aminomethyl)-3-(4-methoxyphenyl)dihydrofuran-2(3H)-one ((3R,5S)-168). Reage...
Scheme 44: Syntheses of a series of imidazolin-2-one dipeptides 175–177 (for R' and R'' see text). Reagents an...
Scheme 45: Syntheses of (2S,3S)-N-Boc-3-hydroxy-2-hydroxymethylpyrrolidine ((2S,3S)-179). Reagents and conditi...
Scheme 46: Syntheses of enantiomers of 1,4-dideoxy-1,4-imino-ʟ- and -ᴅ-lyxitols (2S,3R,4S)-182 and (2R,3S,4R)-...
Scheme 47: Synthesis of 1,4-dideoxy-1,4-imino-ʟ-ribitol (2S,3S,4R)-182. Reagents and conditions: a) AcOH, CH2Cl...
Scheme 48: Syntheses of 1,4-dideoxy-1,4-imino-ᴅ-arabinitol (2R,3R,4R)-182 and 1,4-dideoxy-1,4-imino-ᴅ-xylitol ...
Scheme 49: Syntheses of natural 2,5-imino-2,5,6-trideoxy-ʟ-gulo-heptitol ((2S,3R,4R,5R)-184) and its C4 epimer...
Scheme 50: Syntheses of (−)-dihydropinidine ((2S,6R)-187a) (R = C3H7) and (2S,6R)-isosolenopsins (2S,6R)-187b ...
Scheme 51: Syntheses of (+)-deoxocassine ((2S,3S,6R)-190a, R = C12H25) and (+)-spectaline ((2S,3S,6R)-190b, R ...
Scheme 52: Synthesis of (−)-microgrewiapine A ((2S,3R,6S)-194a) and (+)-microcosamine A ((2S,3R,6S)-194b). Rea...
Scheme 53: Syntheses of ʟ-1-deoxynojirimycin ((2S,3S,4S,5R)-200), ʟ-1-deoxymannojirimycin ((2S,3S,4S,5S)-200) ...
Scheme 54: Syntheses of 1-deoxy-ᴅ-galacto-homonojirimycin (2R,3S,4R,5S)-211. Reagents and conditions: a) MeONH...
Scheme 55: Syntheses of 7a-epi-hyacinthacine A1 (1S,2R,3R,7aS)-220. Reagents and conditions: a) TfOTBDMS, 2,6-...
Scheme 56: Syntheses of 8-deoxyhyacinthacine A1 ((1S,2R,3R,7aR)-221). Reagents and conditions: a) H2, Pd/C, PT...
Scheme 57: Syntheses of (+)-lentiginosine ((1S,2S,8aS)-227). Reagents and conditions: a) (EtO)2P(O)CH2COOEt, L...
Scheme 58: Syntheses of 8-epi-swainsonine (1S,2R,8S,8aR)-231. Reagents and conditions: a) Ph3P=CHCOOMe, MeOH, ...
Scheme 59: Synthesis of a protected vinylpiperidine (2S,3R)-237, a key intermediate in the synthesis of (−)-sw...
Scheme 60: Synthesis of a modified carbapenem 245. Reagents and conditions: a) AcOEt, LiHMDS, THF, −78 °C, 1.5...
Beilstein J. Org. Chem. 2019, 15, 1612–1704, doi:10.3762/bjoc.15.165
Graphical Abstract
Figure 1: Various drugs having IP nucleus.
Figure 2: Participation percentage of various TMs for the syntheses of IPs.
Scheme 1: CuI–NaHSO4·SiO2-catalyzed synthesis of imidazo[1,2-a]pyridines.
Scheme 2: Experimental examination of reaction conditions.
Scheme 3: One-pot tandem reaction for the synthesis of 2-haloimidazopyridines.
Scheme 4: Mechanistic scheme for the synthesis of 2-haloimidazopyridine.
Scheme 5: Copper-MOF-catalyzed three-component reaction (3-CR) for imidazo[1,2-a]pyridines.
Scheme 6: Mechanism for copper-MOF-driven synthesis.
Scheme 7: Heterogeneous synthesis via titania-supported CuCl2.
Scheme 8: Mechanism involving oxidative C–H functionalization.
Scheme 9: Heterogeneous synthesis of IPs.
Scheme 10: One-pot regiospecific synthesis of imidazo[1,2-a]pyridines.
Scheme 11: Vinyl azide as an unprecedented substrate for imidazo[1,2-a]pyridines.
Scheme 12: Radical pathway.
Scheme 13: Cu(I)-catalyzed transannulation approach for imidazo[1,5-a]pyridines.
Scheme 14: Plausible radical pathway for the synthesis of imidazo[1,5-a]pyridines.
Scheme 15: A solvent-free domino reaction for imidazo[1,2-a]pyridines.
Scheme 16: Cu-NPs-mediated synthesis of imidazo[1,2-a]pyridines.
Scheme 17: CuI-catalyzed synthesis of isoxazolylimidazo[1,2-a]pyridines.
Scheme 18: Functionalization of 4-bromo derivative via Sonogashira coupling reaction.
Scheme 19: A plausible reaction pathway.
Scheme 20: Cu(I)-catalyzed intramolecular oxidative C–H amidation reaction.
Scheme 21: One-pot synthetic reaction for imidazo[1,2-a]pyridine.
Scheme 22: Plausible reaction mechanism.
Scheme 23: Cu(OAc)2-promoted synthesis of imidazo[1,2-a]pyridines.
Scheme 24: Mechanism for aminomethylation/cycloisomerization of propiolates with imines.
Scheme 25: Three-component synthesis of imidazo[1,2-a]pyridines.
Figure 3: Scope of pyridin-2(1H)-ones and acetophenones.
Scheme 26: CuO NPS-promoted A3 coupling reaction.
Scheme 27: Cu(II)-catalyzed C–N bond formation reaction.
Scheme 28: Mechanism involving Chan–Lam/Ullmann coupling.
Scheme 29: Synthesis of formyl-substituted imidazo[1,2-a]pyridines.
Scheme 30: A tandem sp3 C–H amination reaction.
Scheme 31: Probable mechanistic approach.
Scheme 32: Dual catalytic system for imidazo[1,2-a]pyridines.
Scheme 33: Tentative mechanism.
Scheme 34: CuO/CuAl2O4/ᴅ-glucose-promoted 3-CCR.
Scheme 35: A tandem CuOx/OMS-2-based synthetic strategy.
Figure 4: Biomimetic catalytic oxidation in the presence of electron-transfer mediators (ETMs).
Scheme 36: Control experiment.
Scheme 37: Copper-catalyzed C(sp3)–H aminatin reaction.
Scheme 38: Reaction of secondary amines.
Scheme 39: Probable mechanistic pathway.
Scheme 40: Coupling reaction of α-azidoketones.
Scheme 41: Probable pathway.
Scheme 42: Probable mechanism with free energy calculations.
Scheme 43: MCR for cyanated IP synthesis.
Scheme 44: Substrate scope for the reaction.
Scheme 45: Reaction mechanism.
Scheme 46: Probable mechanistic pathway for Cu/ZnAl2O4-catalyzed reaction.
Scheme 47: Copper-catalyzed double oxidative C–H amination reaction.
Scheme 48: Application towards different coupling reactions.
Scheme 49: Reaction mechanism.
Scheme 50: Condensation–cyclization approach for the synthesis of 1,3-diarylated imidazo[1,5-a]pyridines.
Scheme 51: Optimized reaction conditions.
Scheme 52: One-pot 2-CR.
Scheme 53: One-pot 3-CR without the isolation of chalcone.
Scheme 54: Copper–Pybox-catalyzed cyclization reaction.
Scheme 55: Mechanistic pathway catalyzed by Cu–Pybox complex.
Scheme 56: Cu(II)-promoted C(sp3)-H amination reaction.
Scheme 57: Wider substrate applicability for the reaction.
Scheme 58: Plausible reaction mechanism.
Scheme 59: CuI assisted C–N cross-coupling reaction.
Scheme 60: Probable reaction mechanism involving sp3 C–H amination.
Scheme 61: One-pot MCR-catalyzed by CoFe2O4/CNT-Cu.
Scheme 62: Mechanistic pathway.
Scheme 63: Synthetic scheme for 3-nitroimidazo[1,2-a]pyridines.
Scheme 64: Plausible mechanism for CuBr-catalyzed reaction.
Scheme 65: Regioselective synthesis of halo-substituted imidazo[1,2-a]pyridines.
Scheme 66: Synthesis of 2-phenylimidazo[1,2-a]pyridines.
Scheme 67: Synthesis of diarylated compounds.
Scheme 68: CuBr2-mediated one-pot two-component oxidative coupling reaction.
Scheme 69: Decarboxylative cyclization route to synthesize 1,3-diarylimidazo[1,5-a]pyridines.
Scheme 70: Mechanistic pathway.
Scheme 71: C–H functionalization reaction of enamines to produce diversified heterocycles.
Scheme 72: A plausible mechanism.
Scheme 73: CuI-promoted aerobic oxidative cyclization reaction of ketoxime acetates and pyridines.
Scheme 74: CuI-catalyzed pathway for the formation of imidazo[1,2-a]pyridine.
Scheme 75: Mechanistic pathway.
Scheme 76: Mechanistic rationale for the synthesis of products.
Scheme 77: Copper-catalyzed synthesis of vinyloxy-IP.
Scheme 78: Regioselective product formation with propiolates.
Scheme 79: Proposed mechanism for vinyloxy-IP formation.
Scheme 80: Regioselective synthesis of 3-hetero-substituted imidazo[1,2-a]pyridines with different reaction su...
Scheme 81: Mechanistic pathway.
Scheme 82: CuI-mediated synthesis of 3-formylimidazo[1,2-a]pyridines.
Scheme 83: Radical pathway for 3-formylated IP synthesis.
Scheme 84: Pd-catalyzed urea-cyclization reaction for IPs.
Scheme 85: Pd-catalyzed one-pot-tandem amination and intramolecular amidation reaction.
Figure 5: Scope of aniline nucleophiles.
Scheme 86: Pd–Cu-catalyzed Sonogashira coupling reaction.
Scheme 87: One-pot amide coupling reaction for the synthesis of imidazo[4,5-b]pyridines.
Scheme 88: Urea cyclization reaction for the synthesis of two series of pyridines.
Scheme 89: Amidation reaction for the synthesis of imidazo[4,5-b]pyridines.
Figure 6: Amide scope.
Scheme 90: Pd NPs-catalyzed 3-component reaction for the synthesis of 2,3-diarylated IPs.
Scheme 91: Plausible mechanistic pathway for Pd NPs-catalyzed MCR.
Scheme 92: Synthesis of chromenoannulated imidazo[1,2-a]pyridines.
Scheme 93: Mechanism for the synthesis of chromeno-annulated IPs.
Scheme 94: Zinc oxide NRs-catalyzed synthesis of imidazo[1,2-a]azines/diazines.
Scheme 95: Zinc oxide-catalyzed isocyanide based GBB reaction.
Scheme 96: Reaction pathway for ZnO-catalyzed GBB reaction.
Scheme 97: Mechanistic pathway.
Scheme 98: ZnO NRs-catalyzed MCR for the synthesis of imidazo[1,2-a]azines.
Scheme 99: Ugi type GBB three-component reaction.
Scheme 100: Magnetic NPs-catalyzed synthesis of imidazo[1,2-a]pyridines.
Scheme 101: Regioselective synthesis of 2-alkoxyimidazo[1,2-a]pyridines catalyzed by Fe-SBA-15.
Scheme 102: Plausible mechanistic pathway for the synthesis of 2-alkoxyimidazopyridine.
Scheme 103: Iron-catalyzed synthetic approach.
Scheme 104: Iron-catalyzed aminooxygenation reaction.
Scheme 105: Mechanistic pathway.
Scheme 106: Rh(III)-catalyzed double C–H activation of 2-substituted imidazoles and alkynes.
Scheme 107: Plausible reaction mechanism.
Scheme 108: Rh(III)-catalyzed non-aromatic C(sp2)–H bond activation–functionalization for the synthesis of imid...
Scheme 109: Reactivity and selectivity of different substrates.
Scheme 110: Rh-catalyzed direct C–H alkynylation by Li et al.
Scheme 111: Suggested radical mechanism.
Scheme 112: Scandium(III)triflate-catalyzed one-pot reaction and its mechanism for the synthesis of benzimidazo...
Scheme 113: RuCl3-assisted Ugi-type Groebke–Blackburn condensation reaction.
Scheme 114: C-3 aroylation via Ru-catalyzed two-component reaction.
Scheme 115: Regioselective synthetic mechanism.
Scheme 116: La(III)-catalyzed one-pot GBB reaction.
Scheme 117: Mechanistic approach for the synthesis of imidazo[1,2-a]pyridines.
Scheme 118: Synthesis of imidazo[1,2-a]pyridine using LaMnO3 NPs under neat conditions.
Scheme 119: Mechanistic approach.
Scheme 120: One-pot 3-CR for regioselective synthesis of 2-alkoxy-3-arylimidazo[1,2-a]pyridines.
Scheme 121: Formation of two possible products under optimization of the catalysts.
Scheme 122: Mechanistic strategy for NiFe2O4-catalyzed reaction.
Scheme 123: Two-component reaction for synthesizing imidazodipyridiniums.
Scheme 124: Mechanistic scheme for the synthesis of imidazodipyridiniums.
Scheme 125: CuI-catalyzed arylation of imidazo[1,2-a]pyridines.
Scheme 126: Mechanism for arylation reaction.
Scheme 127: Cupric acetate-catalyzed double carbonylation approach.
Scheme 128: Radical mechanism for double carbonylation of IP.
Scheme 129: C–S bond formation reaction catalyzed by cupric acetate.
Scheme 130: Cupric acetate-catalyzed C-3 formylation approach.
Scheme 131: Control experiments for signifying the role of DMSO and oxygen.
Scheme 132: Mechanism pathway.
Scheme 133: Copper bromide-catalyzed CDC reaction.
Scheme 134: Extension of the substrate scope.
Scheme 135: Plausible radical pathway.
Scheme 136: Transannulation reaction for the synthesis of imidazo[1,5-a]pyridines.
Scheme 137: Plausible reaction pathway for denitrogenative transannulation.
Scheme 138: Cupric acetate-catalyzed C-3 carbonylation reaction.
Scheme 139: Plausible mechanism for regioselective C-3 carbonylation.
Scheme 140: Alkynylation reaction at C-2 of 3H-imidazo[4,5-b]pyridines.
Scheme 141: Two-way mechanism for C-2 alkynylation of 3H-imidazo[4,5-b]pyridines.
Scheme 142: Palladium-catalyzed SCCR approach.
Scheme 143: Palladium-catalyzed Suzuki coupling reaction.
Scheme 144: Reaction mechanism.
Scheme 145: A phosphine free palladium-catalyzed synthesis of C-3 arylated imidazopyridines.
Scheme 146: Palladium-mediated Buchwald–Hartwig cross-coupling reaction.
Figure 7: Structure of the ligands optimized.
Scheme 147: Palladium acetate-catalyzed direct arylation of imidazo[1,2-a]pyridines.
Scheme 148: Palladium acetate-catalyzed mechanistic pathway.
Scheme 149: Palladium acetate-catalyzed regioselective arylation reported by Liu and Zhan.
Scheme 150: Mechanism for selective C-3 arylation of IP.
Scheme 151: Pd(II)-catalyzed alkenylation reaction with styrenes.
Scheme 152: Pd(II)-catalyzed alkenylation reaction with acrylates.
Scheme 153: A two way mechanism.
Scheme 154: Double C–H activation reaction catalyzed by Pd(OAc)2.
Scheme 155: Probable mechanism.
Scheme 156: Palladium-catalyzed decarboxylative coupling.
Scheme 157: Mechanistic cycle for decarboxylative arylation reaction.
Scheme 158: Ligand-free approach for arylation of imidazo[1,2-a]pyridine-3-carboxylic acids.
Scheme 159: Mechanism for ligandless arylation reaction.
Scheme 160: NHC-Pd(II) complex assisted arylation reaction.
Scheme 161: C-3 arylation of imidazo[1,2-a]pyridines with aryl bromides catalyzed by Pd(OAc)2.
Scheme 162: Pd(II)-catalyzed C-3 arylations with aryl tosylates and mesylates.
Scheme 163: CDC reaction for the synthesis of imidazo[1,2-a]pyridines.
Scheme 164: Plausible reaction mechanism for Pd(OAc)2-catalyzed synthesis of imidazo[1,2-a]pyridines.
Scheme 165: Pd-catalyzed C–H amination reaction.
Scheme 166: Mechanism for C–H amination reaction.
Scheme 167: One-pot synthesis for 3,6-di- or 2,3,6-tri(hetero)arylimidazo[1,2-a]pyridines.
Scheme 168: C–H/C–H cross-coupling reaction of IPs and azoles catalyzed by Pd(II).
Scheme 169: Mechanistic cycle.
Scheme 170: Rh-catalyzed C–H arylation reaction.
Scheme 171: Mechanistic pathway for C–H arylation of imidazo[1,2-a]pyridine.
Scheme 172: Rh(III)-catalyzed double C–H activation of 2-phenylimidazo[1,2-a]pyridines and alkynes.
Scheme 173: Rh(III)-catalyzed mechanistic pathway.
Scheme 174: Rh(III)-mediated oxidative coupling reaction.
Scheme 175: Reactions showing functionalization of the product obtained by the group of Kotla.
Scheme 176: Mechanism for Rh(III)-catalyzed oxidative coupling reaction.
Scheme 177: Rh(III)-catalyzed C–H activation reaction.
Scheme 178: Mechanistic cycle.
Scheme 179: Annulation reactions of 2-arylimidazo[1,2-a]pyridines and alkynes.
Scheme 180: Two-way reaction mechanism for annulations reaction.
Scheme 181: [RuCl2(p-cymene)]2-catalyzed C–C bond formation reaction.
Scheme 182: Reported reaction mechanism.
Scheme 183: Fe(III) catalyzed C-3 formylation approach.
Scheme 184: SET mechanism-catalyzed by Fe(III).
Scheme 185: Ni(dpp)Cl2-catalyzed KTC coupling.
Scheme 186: Pd-catalyzed SM coupling.
Scheme 187: Vanadium-catalyzed coupling of IP and NMO.
Scheme 188: Mechanistic cycle.
Scheme 189: Selective C3/C5–H bond functionalizations by mono and bimetallic systems.
Scheme 190: rGO-Ni@Pd-catalyzed C–H bond arylation of imidazo[1,2-a]pyridine.
Scheme 191: Mechanistic pathway for heterogeneously catalyzed arylation reaction.
Scheme 192: Zinc triflate-catalyzed coupling reaction of substituted propargyl alcohols.
Beilstein J. Org. Chem. 2019, 15, 727–732, doi:10.3762/bjoc.15.68
Graphical Abstract
Figure 1: (a) Isomerization of parent diazocine 1. Distances of carbon atoms para to the ethylene bridge were...
Figure 2: Synthesized target diazocines 4–7 for applications in responsive materials.
Scheme 1: Key reactions in diazocine synthesis.
Scheme 2: Syntheses of the functionalized diazocines 4–7. Reaction conditions: i) Isobutylene, sulfuric acid,...
Figure 3: UV–vis spectra of 3,3’-diaminodiazocine 2 (left), 3,3’-di(aminomethyl)diazocine 6a (center), and 3,...
Beilstein J. Org. Chem. 2019, 15, 584–601, doi:10.3762/bjoc.15.54
Graphical Abstract
Figure 1: Cyclopropene-modified mannosamine, glucosamine and galactosamine derivatives employed for MGE.
Figure 2: A) Reaction of ManNCyc and ManNCp, respectively, with Tz-PEG-OH to determine second-order rate cons...
Scheme 1: MGE with cyclopropene-modified mannosamines. Cells were grown with sugar for 48 hours and then incu...
Figure 3: HEK 293T cells were grown with 100 μM Ac4ManNCyc, Ac4ManNCp, Ac4ManNCyoc or DMSO only (negative con...
Scheme 2: Synthesis of Ac4ManNCp(H2) and Ac4ManNCyc(H2) and the corresponding DMB-labeled sialic acids. C/A =...
Scheme 3: Synthesis of Ac4ManNCyoc(H2) and the corresponding DMB-labeled sialic acid.
Scheme 4: Synthesis of Ac4GlcNCp and Ac4GalNCp.
Figure 4: HEK 293T cells were grown with 100 μM Ac4ManNCp, Ac4GlcNCp, Ac4GalNCp or DMSO only (negative contro...
Figure 5: HEK 293T cells were grown with 100 μM Ac4GlcNCp, Ac4GalNCp or DMSO only (negative control) for 48 h...
Figure 6: HEK 293T cells were grown with 50 μM (A) or 100 μM (B) Ac4GlcNCp, Ac4GlcNCyoc or DMSO only (negativ...
Figure 7: Western blot analysis of soluble glycoproteins. HEK 293T cells were grown for 48 h with 100 μM Ac4M...
Scheme 5: Synthesis of Ac4GlcNCp(H2) and Ac4GlcNCyoc(H2).
Beilstein J. Org. Chem. 2019, 15, 558–566, doi:10.3762/bjoc.15.50
Graphical Abstract
Figure 1: a) CAD drawing of the reactor R1. b) 3D-printed reactor R1 from the CAD drawing. The reactor is fil...
Figure 2: a) L-shaped rail made of PLA with the mounted reactor R3. The small picture shows the fixed reactor...
Figure 3: a) Microreactor R4 with a reactor volume of 12 µL filled with a blue dye solution. b) Magnification...
Figure 4: CAD drawing of two CSTR with three (a) and two inlets (b) with in-printed screw nuts 1/4’’ – 28 thr...
Figure 5: a) Unassembled parts used for one syringe pump. b) Assembled pump with controller.
Scheme 1: Preparation of acetobromo-α-D-glucose 2.
Figure 6: a) Schematic diagram for the continuous-flow synthesis of acetobromo-α-D-glucose 2. b) Photograph o...
Scheme 2: Flow Koenigs–Knorr reaction to methyl glycoside 3 with silver triflate.
Scheme 3: Preparation of glycosyl donor 5.
Scheme 4: Two-step glycosylation reactions starting from pyranose 3.
Scheme 5: Synthesis of azide-functionalized glycopyranoside 8.
Beilstein J. Org. Chem. 2019, 15, 474–489, doi:10.3762/bjoc.15.41
Graphical Abstract
Figure 1: Examples of fluorescent purine/7-deazapurine derivatives.
Scheme 1: General synthetic routes for the compounds 5, 7–9, 10 and 11. Method A: alkyl halogenide, MeCN or D...
Figure 2: 1H NMR spectra of compound 6b in CD3CN at different temperatures (300 MHz, c = 12.5 mg/mL); a, b, c...
Figure 3: Comparison of 1H NMR spectra of compounds 8a and 5 (300 MHz, CDCl3).
Figure 4: a) Experimental UV–vis absorption spectra (lines) with computed theoretical absorption bands (colum...
Figure 5: Photos of compound 8c (A and B) and compound 11c (C and D) in THF, CHCl3, DMSO, MeCN and MeOH befor...
Figure 6: a) Fluorescence spectra of compounds 8c (λexc = 360 nm) and 11c (λexc = 370 nm) in solvents of diff...
Figure 7: Energy diagram for the frontier molecular orbitals of compounds 8a, 8c, 11a and 11c.
Figure 8: Labeled MCF-7 cells using compound 9 (C,D) and unlabeled MCF-7 cells (A,B) in microscope (2 h, c(9)...
Beilstein J. Org. Chem. 2019, 15, 333–350, doi:10.3762/bjoc.15.29
Graphical Abstract
Scheme 1: Representative strategies for the formation of alkylidenecyclopropanes from cyclopropenes and scope...
Scheme 2: [2,3]-Sigmatropic rearrangement of phosphinites 2a–h.
Scheme 3: [2,3]-Sigmatropic rearrangement of a phosphinite derived from enantioenriched cyclopropenylcarbinol...
Scheme 4: Selective reduction of phosphine oxide (E)-3f.
Scheme 5: Attempted thermal [2,3]-sigmatropic rearrangement of phosphinite 6a.
Scheme 6: Computed activation barriers and free enthalpies.
Scheme 7: [2,3]-Sigmatropic rearrangement of phosphinites 6a–j.
Scheme 8: Proposed mechanism for the Lewis base-catalyzed rearrangement of phosphinites 6.
Scheme 9: [3,3]-Sigmatropic rearrangement of tertiary cyclopropenylcarbinyl acetates 10a–c.
Scheme 10: [3,3]-Sigmatropic rearrangement of secondary cyclopropenylcarbinyl esters 10d–h.
Scheme 11: [3,3]-Sigmatropic rearrangement of trichoroacetimidates 12a–i.
Scheme 12: Reaction of trichloroacetamide 13f with pyrrolidine.
Scheme 13: Catalytic hydrogenation of (arylmethylene)cyclopropropane 13f.
Scheme 14: Instability of trichloroacetimidates 21a–c derived from cyclopropenylcarbinols 20a–c.
Scheme 15: [3,3]-Sigmatropic rearrangement of cyanate 27 generated from cyclopropenylcarbinyl carbamate 26.
Scheme 16: Synthesis of alkylidene(aminocyclopropane) derivatives 30–37 from carbamate 26.
Scheme 17: Scope of the dehydration–[3,3]-sigmatropic rearrangement sequence of cyclopropenylcarbinyl carbamat...
Scheme 18: Formation of trifluoroacetamide 50 from carbamate 49.
Scheme 19: Formation of alkylidene[(N-trifluoroacetylamino)cyclopropanes] 51–54.
Scheme 20: Diastereoselective hydrogenation of alkylidenecyclopropane 51.
Scheme 21: Ireland–Claisen rearrangement of cyclopropenylcarbinyl glycolates 56a–l.
Scheme 22: Synthesis and Ireland–Claisen rearrangement of glycolate 61 possessing gem-diester substitution at ...
Scheme 23: Synthesis of alkylidene(gem-difluorocyclopropanes) 66a–h, and 66k–n from propargyl glycolates 64a–n....
Scheme 24: Ireland–Claisen rearrangement of N,N-diBoc glycinates 67a and 67b.
Scheme 25: Diastereoselective hydrogenation of alkylidenecyclopropanes 58a and 74.
Scheme 26: Synthesis of functionalized gem-difluorocyclopropanes 76 and 77 from alkylidenecyclopropane 66a.
Scheme 27: Access to oxa- and azabicyclic compounds 78–80.
Beilstein J. Org. Chem. 2019, 15, 256–278, doi:10.3762/bjoc.15.23
Graphical Abstract
Scheme 1: The oxidative radical ring-opening/cyclization of cyclopropane derivatives.
Scheme 2: Mn(OAc)3-mediated oxidative radical ring-opening and cyclization of MCPs with malonates.
Scheme 3: Mn(III)-mediated oxidative radical ring-opening and cyclization of MCPs with 1,3-dicarbonyl compoun...
Scheme 4: Heat-promoted ring-opening/cyclization of MCPs with elemental chalgogens.
Scheme 5: Copper(II) acetate-mediated oxidative radical ring-opening and cyclization of MCPs with diphenyl di...
Scheme 6: AIBN-promoted oxidative radical ring-opening and cyclization of MCPs with benzenethiol.
Scheme 7: AIBN-mediated oxidative radical ring-opening and cyclization of MCPs with diethyl phosphites.
Scheme 8: Organic-selenium induced radical ring-opening and cyclization of MCPs derivatives (cyclopropylaldeh...
Scheme 9: Copper(I)-catalyzed oxidative radical trifluoromethylation/ring-opening/cyclization of MCPs with To...
Scheme 10: Ag(I)-mediated trifluoromethylthiolation/ring-opening/cyclization of MCPs with AgSCF3.
Scheme 11: oxidative radical ring-opening and cyclization of MCPs with α-C(sp3)-–H of ethers.
Scheme 12: Oxidative radical ring-opening and cyclization of MCPs with aldehydes.
Scheme 13: Cu(I) or Fe(II)-catalyzed oxidative radical trifluoromethylation/ring-opening/cyclization of MCPs d...
Scheme 14: Rh(II)-catalyzed oxidative radical ring-opening and cyclization of MCPs.
Scheme 15: Ag(I)-catalyzed oxidative radical amination/ring-opening/cyclization of MCPs derivatives.
Scheme 16: Heating-promoted radical ring-opening and cyclization of MCP derivatives (arylvinylidenecyclopropan...
Scheme 17: Bromine radical-mediated ring-opening of alkylidenecyclopropanes.
Scheme 18: Fluoroalkyl (Rf) radical-mediated ring-opening of MCPs.
Scheme 19: Visible-light-induced alkylation/ring-opening/cyclization of cyclopropyl olefins with bromides.
Scheme 20: Mn(III)-mediated ring-opening and [3 + 3]-annulation of cyclopropanols and vinyl azides.
Scheme 21: Ag(I)-catalyzed oxidative ring-opening of cyclopropanols with quinones.
Scheme 22: Ag(I)-catalyzed oxidative ring-opening of cyclopropanols with heteroarenes.
Scheme 23: Cu(I)-catalyzed oxidative ring-opening/trifluoromethylation of cyclopropanols.
Scheme 24: Cu(I)-catalyzed oxidative ring-opening and trifluoromethylation/trifluoromethylthiolation of cyclop...
Scheme 25: Ag(I)-mediated oxidative ring-opening/fluorination of cyclopropanols with Selectfluor.
Scheme 26: Photocatalyzed ring-opening/fluorination of cyclopropanols with Selectfluor.
Scheme 27: Na2S2O8-promoted ring-opening/alkynylation of cyclopropanols with EBX.
Scheme 28: Ag(I)-catalyzed ring-opening and chlorination of cyclopropanols with aldehydes.
Scheme 29: Ag(I)-catalyzed ring-opening/alkynylation of cyclopropanols with EBX.
Scheme 30: Na2S2O8-promoted ring-opening/alkylation of cyclopropanols with acrylamides.
Scheme 31: Cyclopropanol ring-opening initiated tandem cyclization with acrylamides or 2-isocyanobiphenyls.
Scheme 32: Ag(II)-mediated oxidative ring-opening/fluorination of cyclopropanols with AgF2.
Scheme 33: Cu(II)-catalyzed ring-opening/fluoromethylation of cyclopropanols with sulfinate salts.
Scheme 34: Cu(II)-catalyzed ring-opening/sulfonylation of cyclopropanols with sulfinate salts.
Scheme 35: Na2S2O8-promoted ring-opening/arylation of cyclopropanols with propiolamides.
Scheme 36: The ring-opening and [3 + 2]-annulation of cyclopropanols with α,β-unsaturated aldehydes.
Scheme 37: Cu(II)-catalyzed ring-opening/arylation of cyclopropanols with aromatic nitrogen heterocyles.
Scheme 38: Ag(I)-catalyzed ring-opening and difluoromethylthiolation of cyclopropanols with PhSO2SCF2H.
Scheme 39: Ag(I)-catalyzed ring-opening and acylation of cyclopropanols with aldehydes.
Scheme 40: Aerobic oxidation ring-opening of cyclopropanols for the synthesis of 2-oxyranyl ketones.
Scheme 41: Aerobic oxidation ring-opening of cyclopropanols for the synthesis of linear enones.
Scheme 42: Aerobic oxidation ring-opening of cyclopropanols for the synthesis of metabolite.
Beilstein J. Org. Chem. 2018, 14, 2916–2922, doi:10.3762/bjoc.14.270
Graphical Abstract
Scheme 1: General methods for the synthesis of triazoles.
Scheme 2: Substrate scope of the terminal alkynes. Conditions: 1 (0.5 mmol), 2a (0.75 mmol), TMSN3 (0.75 mmol...
Scheme 3: Substrate scope of the alkyl diacyl peroxides. Conditions: 1a (0.5 mmol), 2 (0.75 mmol), TMSN3 (0.7...
Scheme 4: Preliminary mechanistic studies.
Scheme 5: Plausible reaction mechanism.
Beilstein J. Org. Chem. 2018, 14, 2689–2697, doi:10.3762/bjoc.14.246
Graphical Abstract
Scheme 1: Two-step reaction towards triazolochromene 5a and obtained oxidized side product 6.
Scheme 2: Reaction pathways leading to the different regioisomers.
Figure 1: Scope with respect to various salicylaldehydes 1a–f, nitroalkenes 2a–d and organic azides 4a–g. aRe...
Scheme 3: Synthesis of bis-chromenotriazole 5p.
Figure 2: Generality of products obtained via the two-pot mechanochemical procedure, varying the salicylaldeh...
Scheme 4: Scale-up of the one-pot three-component reaction and two-step ball milling procedure.
Scheme 5: Postfunctional transformations of triazolochromenes.
Beilstein J. Org. Chem. 2018, 14, 2348–2353, doi:10.3762/bjoc.14.210
Graphical Abstract
Figure 1: Scope of the water-mediated synthesis of 4-acyl-NH-1,2,3-triazoles. General conditions: enaminone 1...
Scheme 1: The gram scale synthesis of 3a: (a) before reaction; (b) completed reaction; (c) the purified produ...
Scheme 2: The proposed reaction mechanism.
Beilstein J. Org. Chem. 2018, 14, 1980–1993, doi:10.3762/bjoc.14.173
Graphical Abstract
Scheme 1: The general structure of triazolylcalix[4]arene derivatives.
Scheme 2: Synthesis of di- (4a,b) and tetraazido (8a,b) calix[4]arene derivatives. Conditions: Ia: AlkBr, K2CO...
Figure 1: Molecular structure of 8a (50% ellipsoids). The dashed line indicates the alternative position of t...
Scheme 3: Synthesis of polyammonium macrocycles 10a,b and 12a,b.
Figure 2: 2D NOESY H1-H1 NMR spectra of 10b in DMSO-d6.
Figure 3: The optical response (OR) of the calixarene/EY systems toward adenosine phosphates. Concentration (...
Figure 4: Supramolecular binding motif of diphosphate (a) and triphosphate (b) groups of nucleotides with the...
Figure 5: UV spectra of EY (1), 10b–EY (2), and 10b–EY in the presence of 0.005 (3), 0.05 (4), 0.5 (5) and 2 ...
Scheme 4: Structure of AEPDA and the corresponding AEPCDA–10b polydiacetylene vesicle.
Figure 6: UV spectra of the AEPCDA polydiacetylene vesicles in the presence of different amounts of 10b; conc...
Figure 7: Photographs of a portion of a 96-well plate containing AEPCDA–10b polydiacetylene vesicles in the a...
Beilstein J. Org. Chem. 2018, 14, 1946–1955, doi:10.3762/bjoc.14.169
Graphical Abstract
Figure 1: Schematic illustration of possible support-assisted methods.
Figure 2: Expected reactivity of 5’- and 3’-terminus for the activation.
Scheme 1: Competition experiment between alcohol and carboxylic acid. Reagents and conditions: (i) 4-phenylbu...
Scheme 2: Conjugation between the 5’-activated supported trinucleotide 2 and the tripeptide 3. Reagents and c...
Figure 3: HPLC spectra of the crude protected bioconjugate 4 and the crude deprotected bioconjugate 5.
Scheme 3: 5’-Phosphitylation of supported decanucleotide 13. Reagents and conditions: 2-cyanoethyl-N,N,N',N'-...
Scheme 4: Conjugation between 5’-activated supported decanucleotide 14 and supported pentapeptide 7. Reagents...
Figure 4: HPLC spectra of the crude protected bioconjugate 15 and the deprotected bioconjugate 16.
Beilstein J. Org. Chem. 2018, 14, 1890–1900, doi:10.3762/bjoc.14.163
Graphical Abstract
Figure 1: Principle of photoaffinity labeling of proteins with diazirine derivatives. Photolabile ligands are...
Figure 2: FimH crystal structure (pdb code 1KLF) with docked p-nitrophenyl α-D-mannopyranoside (1, pNPMan). F...
Figure 3: Based on the structure of the known FimH ligands 1 and 2, three photolabile α-D-mannosides, 3–5, we...
Figure 4: Connolly representation of photolabile α-D-mannoside 3 in the closed gate (A, PDB code 1UWF) and op...
Scheme 1: Synthesis of photolabile α-D-mannosides 3 and 4. a) H2, Pd-C, methanol, rt, 6 h, 94%; b) HATU, DIPE...
Figure 5: ESIMS spectra of peptide M2 before (A) and after photoreaction (B) with mannoside 3.
Figure 6: Intact protein ESIMS spectra of FimHtr labeling with diazirine derivative 3 with (A) 50% acetonitri...
Beilstein J. Org. Chem. 2018, 14, 1846–1853, doi:10.3762/bjoc.14.158
Graphical Abstract
Scheme 1: Diazide and dialkyne building blocks used in this study.
Scheme 2: Synthesis of Cat-1 by CBAAC. aAssembly yield by HPLC; bisolated yield as PF6− salt.
Scheme 3: Synthesis of [3]catenanes by CBAAC. aAssembly yield by HPLC; bisolated yield by precipitation as PF6...
Figure 1: 1H NMR (500 MHz, D2O, 298 K) of Cat-2. The signal at ca. 8.3 ppm is the residual formate from prepa...
Figure 2: (a) ESIMS, (b) HRMS, and (c) MS2 spectrum (parent ion at m/z = 887.8) of Cat-2.
Scheme 4: Synthesis of the [4]catenane Cat-11. aAssembly yield by HPLC; bisolated yield by preparative HPLC.
Beilstein J. Org. Chem. 2018, 14, 1668–1692, doi:10.3762/bjoc.14.143
Graphical Abstract
Figure 1: Some sulfur-containing natural products.
Figure 2: Some natural products incorporating β-hydroxy sulfide moieties.
Figure 3: Some synthetic β-hydroxy sulfides of clinical value.
Scheme 1: Alumina-mediated synthesis of β-hydroxy sulfides, ethers, amines and selenides from epoxides.
Scheme 2: β-Hydroxy sulfide syntheses by ring opening of epoxides under different Lewis and Brønsted acid and...
Scheme 3: n-Bu3P-catalyzed thiolysis of epoxides and aziridines to provide the corresponding β-hydroxy and β-...
Scheme 4: Zinc(II) chloride-mediated thiolysis of epoxides.
Scheme 5: Thiolysis of epoxides and one-pot oxidation to β-hydroxy sulfoxides under microwave irradiation.
Scheme 6: Gallium triflate-catalyzed ring opening of epoxides and one-pot oxidation.
Scheme 7: Thiolysis of epoxides and one-pot oxidation to β-hydroxy sulfoxides using Ga(OTf)3 as a catalyst.
Scheme 8: Ring opening of epoxide using ionic liquids under solvent-free conditions.
Scheme 9: N-Bromosuccinimide-catalyzed ring opening of epoxides.
Scheme 10: LiNTf2-mediated epoxide opening by thiophenol.
Scheme 11: Asymmetric ring-opening of cyclohexene oxide with various thiols catalyzed by zinc L-tartrate.
Scheme 12: Catalytic asymmetric ring opening of symmetrical epoxides with t-BuSH catalyzed by (R)-GaLB (43) wi...
Scheme 13: Asymmetric ring opening of meso-epoxides by p-xylenedithiol catalyzed by a (S,S)-(salen)Cr complex.
Scheme 14: Desymmetrization of meso-epoxide with thiophenol derivatives.
Scheme 15: Enantioselective ring-opening reaction of meso-epoxides with ArSH catalyzed by a C2-symmetric chira...
Scheme 16: Enantioselective ring-opening reaction of stilbene oxides with ArSH catalyzed by a C2-symmetric chi...
Scheme 17: Asymmetric desymmetrization of meso-epoxides using BINOL-based Brønsted acid catalysts.
Scheme 18: Lithium-BINOL-phosphate-catalyzed desymmetrization of meso-epoxides with aromatic thiols.
Scheme 19: Ring-opening reactions of cyclohexene oxide with thiols by using CPs 1-Eu and 2-Tb.
Scheme 20: CBS-oxazaborolidine-catalyzed borane reduction of β-keto sulfides.
Scheme 21: Preparation of β-hydroxy sulfides via connectivity.
Scheme 22: Baker’s yeast-catalyzed reduction of sulfenylated β-ketoesters.
Scheme 23: Sodium-mediated ring opening of epoxides.
Scheme 24: Disulfide bond cleavage-epoxide opening assisted by tetrathiomolybdate.
Scheme 25: Proposed reaction mechanism of disulfide bond cleavage-epoxide opening assisted by tetrathiomolybda...
Scheme 26: Cyclodextrin-catalyzed difunctionalization of alkenes.
Scheme 27: Zinc-catalyzed synthesis of β-hydroxy sulfides from disulfides and alkenes.
Scheme 28: tert-Butyl hydroperoxide-catalyzed hydroxysulfurization of alkenes.
Scheme 29: Proposed mechanism of the radical hydroxysulfurization.
Scheme 30: Rongalite-mediated synthesis of β-hydroxy sulfides from styrenes and disulfides.
Scheme 31: Proposed mechanism of Rongalite-mediated synthesis of β-hydroxy sulfides from styrenes and disulfid...
Scheme 32: Copper(II)-catalyzed synthesis of β-hydroxy sulfides 15e,f from alkenes and basic disulfides.
Scheme 33: CuI-catalyzed acetoxysulfenylation of alkenes.
Scheme 34: CuI-catalyzed acetoxysulfenylation reaction mechanism.
Scheme 35: One-pot oxidative 1,2-acetoxysulfenylation of Baylis–Hillman products.
Scheme 36: Proposed mechanism for the oxidative 1,2-acetoxysulfination of Baylis–Hillman products.
Scheme 37: 1,2-Acetoxysulfenylation of alkenes using DIB/KI.
Scheme 38: Proposed reaction mechanism of the diacetoxyiodobenzene (DIB) and KI-mediated 1,2-acetoxysulfenylat...
Scheme 39: Catalytic asymmetric thiofunctionalization of unactivated alkenes.
Scheme 40: Proposed catalytic cycle for asymmetric sulfenofunctionalization.
Scheme 41: Synthesis of thiosugars using intramolecular thiol-ene reaction.
Scheme 42: Synthesis of leukotriene C-1 by Corey et al.: (a) N-(trifluoroacetyl)glutathione dimethyl ester (3 ...
Scheme 43: Synthesis of pteriatoxins with epoxide thiolysis to attain β-hydroxy sulfides. Reagents: (a) (1) K2...
Scheme 44: Synthesis of peptides containing a β-hydroxy sulfide moiety.
Scheme 45: Synthesis of diltiazem (12) using biocatalytic resolution of an epoxide followed by thiolysis.
Beilstein J. Org. Chem. 2018, 14, 1619–1636, doi:10.3762/bjoc.14.138
Graphical Abstract
Scheme 1: Left: The Mitsunobu reaction is essentially a nucleophilic substitution of alcohols occurring with ...
Scheme 2: Mechanistic considerations on the Mitsunobu reaction with carbohydrate hemiacetals (depicted in sim...
Scheme 3: Anomeric esterification using the Mitsunobu procedure [29].
Scheme 4: Conversion of allyl glucuronate into various 1-O-esterified allyl glucuronates using anomeric Mitsu...
Scheme 5: Synthesis of anomeric glycosyl esters as substrates for Au-catalyzed glycosylation [40].
Scheme 6: Correlation between pKa value of the employed acids (or alcohol) and the favoured anomeric configur...
Scheme 7: Synthesis of the β-mannosyl phosphates for the synthesis of HBP 43 by anomeric phosphorylation acco...
Scheme 8: Synthesis of phenyl glycosides 44 and 45 from unprotected sugars [24].
Scheme 9: Synthesis of azobenzene mannosides 47 and 48 without protecting group chemistry [46].
Scheme 10: Synthesis of various aryl sialosides using Mitsunobu glycosylation [25].
Scheme 11: Mitsunobu synthesis of different jadomycins [54,55]. BOM: benzyloxymethyl.
Scheme 12: Stereoselectivity in the Mitsunobu synthesis of catechol glycosides in the gluco- and manno-series [56]....
Scheme 13: Formation of a 1,2-cis glycoside 80 assisted by steric hindrance of the β-face of the disaccharide ...
Scheme 14: Stereoselective β-D-mannoside synthesis [60].
Scheme 15: TIPS-assisted synthesis of 1,2-cis arabinofuranosides [63]. TIPS: triisopropylsilyl.
Scheme 16: The Mitsunobu reaction with glycals leads to interesting rearrangement products [69].
Scheme 17: Synthesis of disaccharides using mercury(II) bromide as co-activator in the Mitsunobu reaction [75].
Scheme 18: Synthesis of various fructofuranosides according to Mitsunobu and proposed neighbouring group parti...
Scheme 19: The Mitsunobu reaction allows stereoslective acetalization of dihydroartemisinin [77].
Scheme 20: Synthesis of alkyl thioglycosides by Mitsunobu reaction [81].
Scheme 21: Preparation of iminoglycosylphthalimide 115 from 114 [85].
Scheme 22: Mitsunobu reaction as a key step in the total synthesis of aurantoside G [87].
Scheme 23: Utilization of an N–H acid in the Mitsunobu reaction [88].
Scheme 24: Mitsunobu reaction with 1H-tetrazole [89].
Scheme 25: Formation of a rebeccamycin analogue using the Mitsunobu reaction [101].
Scheme 26: Synthesis of carbohydrates with an alkoxyamine bond [114].
Scheme 27: Synthesis of glycosyl fluorides and glycosyl azides according to Mitsunobu [118,119].
Scheme 28: Anomeric oxidation under Mitsunobu conditions [122].
Beilstein J. Org. Chem. 2018, 14, 1317–1348, doi:10.3762/bjoc.14.113
Graphical Abstract
Scheme 1: Thermal reaction of sydnones with symmetrical alkynes.
Scheme 2: Reaction of sydnones with strained cycloalkynes.
Scheme 3: Reaction of sydnones with didehydrobenzenes.
Scheme 4: Formation of isomeric pyrazole dicarboxylates.
Scheme 5: Mechanism of thermal cycloaddition between sydnones and alkynes.
Scheme 6: Mechanism of photochemical reaction of sydnones with symmetrical alkynes.
Scheme 7: HOMO–LUMO diagram for thermal [3 + 2]-cycloaddition of sydnones with alkynes.
Scheme 8: Synthetic strategy leading to 1,2-disubstituted pyrazoles.
Scheme 9: Unsuccessful reaction with phenylpropiolic acid.
Scheme 10: Synthetic strategy leading to 1,4,5-trisubstituted pyrazoles.
Scheme 11: Reaction of sydnones carrying in position 4- six-membered 2-N-heterocyclic ring.
Scheme 12: Strain-promoted sydnone alkyne cycloaddition (SPSAC).
Scheme 13: Synthesis of a key intermediate of niraparib.
Scheme 14: Reaction of sydnones with 1,3-/1,4-benzdiyne equivalents.
Scheme 15: Reaction of sydnones with heterocyclic strained cycloalkynes.
Scheme 16: Mono-copper catalyzed cycloaddition reaction.
Scheme 17: Di-copper catalyzed cycloaddition reaction.
Beilstein J. Org. Chem. 2018, 14, 682–687, doi:10.3762/bjoc.14.56
Beilstein J. Org. Chem. 2018, 14, 506–514, doi:10.3762/bjoc.14.36
Graphical Abstract
Figure 1: Examples of naturally occurring oxazoles (a); some drugs containing oxazole as the active moiety (b...
Scheme 1: Synthesis of oxazoles 4 by addition of acyl chlorides to azirines 2, as described by Hassner et al. ...
Scheme 2: Preparation of 2-functionalized oxazoles 7 from 2-(chloromethyl)oxazoles 6 and their application to...
Scheme 3: Integrated continuous-flow synthesis of 2-(azidomethyl)oxazoles 7.
Scheme 4: Side products generated during the reaction of azirine 2a with bromoacyl bromide at room temperatur...
Figure 2: HPLC monitoring of the formation of 2-(azidomethyl)oxazole 7a.
Figure 3: Continuous sequential thermolysis of vinyl azides 1 and ring expansion of azirines 2 with bromoacet...
Figure 4: Continuous-flow three-step sequential synthesis of 2-(azidomethyl)oxazoles 7a–c from vinyl azides 1a...
Beilstein J. Org. Chem. 2018, 14, 484–498, doi:10.3762/bjoc.14.34
Graphical Abstract
Figure 1: a) Ribbon and b) surface depictions of the cholera toxin: A11 domain in light blue; A12 domain in d...
Figure 2: a) Structure of the cholera toxin showing the location of its carbohydrate binding sites and the st...
Figure 3: Bernardi and co-workers’ designed oligosaccharide mimetics of GM1.
Figure 4: Structure of monomeric ligands. X = amino acid residues, aminoalkyl, 1,2,3 triazoles; n = 1, 2; R =...
Figure 5: Bivalent inhibitor designed and synthesised by Pickens et al.
Figure 6: Bivalent inhibitor designed and synthesized by Arosio et al.
Figure 7: Bivalent inhibitors designed and synthesised by Leaver and Liu.
Figure 8: Bivalent and tetravalent inhibitor designed and synthesised by Pieters, and Bernardi et al.
Figure 9: Cyclic inhibitors synthesised by Kumar et al. for CT.
Figure 10: The star-shaped inhibitors reported by Fan, Hol and co-workers.
Figure 11: Differently sized cyclic decavalent peptide core designed by Zhang et al.
Figure 12: Calix[5]arene core-based pentavalent inhibitor designed by Garcia-Hartjes et al.
Figure 13: Corannulene core-based pentavalent inhibitor designed by Mattarella et al.
Figure 14: Pentavalent inhibitor designed by Pieters and co-workers.
Figure 15: Neoglycoprotein inhibitor based on a non-binding mutant of CTB.
Figure 16: Octavalent inhibitor designed by Pieters, Bernardi and co-workers.
Figure 17: Hetero-bifunctional inhibitor designed by Bundle and co-workers.
Figure 18: Glycopolymers with exchangeable sugar ligands and variable length linkers.
Beilstein J. Org. Chem. 2018, 14, 373–380, doi:10.3762/bjoc.14.25
Graphical Abstract
Scheme 1: Silicon-mediated Mukaiyama-type aldol reaction of octyl 2-(pentafluoro-λ6-sulfanyl)acetate (1) with ...
Figure 1: Newman projections of the syn- and the anti-diastereomeric aldol addition products.
Scheme 2: Mechanism of the formation of aldol addition products.
Scheme 3: Formation of (E)-configured aldol condensation products.
Scheme 4: Anticipated mechanism of formation of aldol condensation products.
Scheme 5: Synthesis of SF5-substituted acetmorpholide 8.
Scheme 6: Intermediate formation of the (Z)-ketene aminal from morpholide 8 with TMSOTf/ Et3N and subsequent ...
Beilstein J. Org. Chem. 2018, 14, 253–281, doi:10.3762/bjoc.14.17
Graphical Abstract
Figure 1: The design of classical DNA molecular beacons.
Figure 2: Structures of DNA and selected PNA systems.
Figure 3: Various binding modes of PNA to double stranded DNA including triplex formation, triplex invasion, ...
Figure 4: The design and working principle of the PNA beacons according to (A) Ortiz et al. [41] and (B) Armitage...
Figure 5: The design of "stemless" PNA beacons.
Figure 6: The applications of PNA openers to facilitate the binding of PNA beacons to double stranded DNA [40,47].
Figure 7: The working principle of snap-to-it probes that employed metal chelation to bring the dyes in close...
Figure 8: Examples of pre-formed dye-labeled PNA monomers and functionalizable PNA monomers.
Figure 9: Dual-labeled PNA beacons with end-stacking or intercalating quencher.
Figure 10: The working principle of hybrid PNA-peptide beacons for detection of (A) proteins [80] and (B) protease...
Figure 11: The working principle of binary probes.
Figure 12: The working principle of nucleic acid templated fluorogenic reactions leading to a (A) ligated prod...
Figure 13: Catalytic cycles in fluorogenic nucleic acid templated reactions [90].
Figure 14: The working principle of strand displacement probes.
Figure 15: (A) Examples of CPP successfully used with labeled PNA probes. (B) The use of single-labeled PNA pr...
Figure 16: The concept of PNA–GO platform for DNA/RNA sensing.
Figure 17: Single-labeled fluorogenic PNA probes.
Figure 18: Examples of environment sensitive fluorescent labels that have been incorporated into PNA probes as...
Figure 19: The mechanism of fluorescence change in TO dye.
Figure 20: Fluorescent nucleobases capable of hydrogen bonding that have been incorporated into PNA probes.
Figure 21: Comparison of the designs of the (A) light-up PNA probe and (B) FIT PNA probe.
Figure 22: The structures of TO and its analogues that have successfully been used in FIT PNA probes.
Figure 23: The working principle of dual-labeled FIT PNA probes [222,223].
Beilstein J. Org. Chem. 2018, 14, 54–83, doi:10.3762/bjoc.14.4
Graphical Abstract
Scheme 1: General overview over the sulfur-based substrates and reactive intermediates that are discussed in ...
Scheme 2: Photoredox-catalyzed radical thiol–ene reaction, applying [Ru(bpz)3](PF6)2 as photocatalyst.
Scheme 3: Photoredox-catalyzed thiol–ene reaction of aliphatic thiols with alkenes enabled by aniline derivat...
Scheme 4: Photoredox-catalyzed radical thiol–ene reaction for the postfunctionalization of polymers (a) and n...
Scheme 5: Photoredox-catalyzed thiol–ene reaction enabled by bromotrichloromethane as redox additive.
Scheme 6: Photoredox-catalyzed preparation of β-ketosulfoxides with Eosin Y as organic dye as photoredox cata...
Scheme 7: Greaney’s photocatalytic radical thiol–ene reaction, applying TiO2 nanoparticles as photocatalyst.
Scheme 8: Fadeyi’s photocatalytic radical thiol–ene reaction, applying Bi2O3 as photocatalyst.
Scheme 9: Ananikov’s photocatalytic radical thiol-yne reaction, applying Eosin Y as photocatalyst.
Scheme 10: Organocatalytic visible-light photoinitiated thiol–ene coupling, applying phenylglyoxylic acid as o...
Scheme 11: Xia’s photoredox-catalyzed synthesis of 2,3-disubstituted benzothiophenes, applying 9-mesityl-10-me...
Scheme 12: Wang’s metal-free photoredox-catalyzed radical thiol–ene reaction, applying 9-mesityl-10-methylacri...
Scheme 13: Visible-light benzophenone-catalyzed metal- and oxidant-free radical thiol–ene reaction.
Scheme 14: Visible-light catalyzed C-3 sulfenylation of indole derivatives using Rose Bengal as organic dye.
Scheme 15: Photocatalyzed radical thiol–ene reaction and subsequent aerobic sulfide-oxidation with Rose Bengal...
Scheme 16: Photoredox-catalyzed synthesis of diaryl sulfides.
Scheme 17: Photocatalytic cross-coupling of aryl thiols with aryl diazonium salts, using Eosin Y as photoredox...
Scheme 18: Photocatalyzed cross-coupling of aryl diazonium salts with cysteines in batch and in a microphotore...
Scheme 19: Fu’s [Ir]-catalyzed photoredox arylation of aryl thiols with aryl halides.
Scheme 20: Fu’s photoredox-catalyzed difluoromethylation of aryl thiols.
Scheme 21: C–S cross-coupling of thiols with aryl iodides via [Ir]-photoredox and [Ni]-dual-catalysis.
Scheme 22: C–S cross-coupling of thiols with aryl bromides, applying 3,7-bis-(biphenyl-4-yl)-10-(1-naphthyl)ph...
Scheme 23: Collin’s photochemical dual-catalytic cross-coupling of thiols with bromoalkynes.
Scheme 24: Visible-light-promoted C–S cross-coupling via intermolecular electron donor–acceptor complex format...
Scheme 25: Li’s visible-light photoredox-catalyzed thiocyanation of indole derivatives with Rose Bengal as pho...
Scheme 26: Hajra’s visible-light photoredox-catalyzed thiocyanation of imidazoheterocycles with Eosin Y as pho...
Scheme 27: Wang’s photoredox-catalyzed thiocyanation reaction of indoles, applying heterogeneous TiO2/MoS2 nan...
Scheme 28: Yadav’s photoredox-catalyzed α-C(sp3)–H thiocyanation reaction for tertiary amines, applying Eosin ...
Scheme 29: Yadav’s photoredox-catalyzed synthesis of 5-aryl-2-imino-1,3-oxathiolanes.
Scheme 30: Yadav’s photoredox-catalyzed synthesis of 1,3-oxathiolane-2-thiones.
Scheme 31: Li’s photoredox catalysis for the preparation of 2-substituted benzothiazoles, applying [Ru(bpy)3](...
Scheme 32: Lei’s external oxidant-free synthesis of 2-substituted benzothiazoles by merging photoredox and tra...
Scheme 33: Metal-free photocatalyzed synthesis of 2-aminobenzothiazoles, applying Eosin Y as photocatalyst.
Scheme 34: Metal-free photocatalyzed synthesis of 1,3,4-thiadiazoles, using Eosin Y as photocatalyst.
Scheme 35: Visible-light photoredox-catalyzed preparation of benzothiophenes with Eosin Y.
Scheme 36: Visible-light-induced KOH/DMSO superbase-promoted preparation of benzothiophenes.
Scheme 37: Jacobi von Wangelin’s photocatalytic approach for the synthesis of aryl sulfides, applying Eosin Y ...
Scheme 38: Visible-light photosensitized α-C(sp3)–H thiolation of aliphatic ethers.
Scheme 39: Visible-light photocatalyzed cross-coupling of alkyl and aryl thiosulfates with aryl diazonium salt...
Scheme 40: Visible-light photocatalyzed, controllable sulfenylation and sulfoxidation with organic thiosulfate...
Scheme 41: Rastogi’s photoredox-catalyzed methylsulfoxidation of aryl diazonium salts, using [Ru(bpy)3]Cl2 as ...
Scheme 42: a) Visible-light metal-free Eosin Y-catalyzed procedure for the preparation of vinyl sulfones from ...
Scheme 43: Visible-light photocatalyzed cross-coupling of sodium sulfinates with secondary enamides.
Scheme 44: Wang’s photocatalyzed oxidative cyclization of phenyl propiolates with sulfinic acids, applying Eos...
Scheme 45: Lei’s sacrificial oxidant-free synthesis of allyl sulfones by merging photoredox and transition met...
Scheme 46: Photocatalyzed Markovnikov-selective radical/radical cross-coupling of aryl sulfinic acids and term...
Scheme 47: Visible-light Eosin Y induced cross-coupling of aryl sulfinic acids and styrene derivatives, afford...
Scheme 48: Photoredox-catalyzed bicyclization of 1,7-enynes with sulfinic acids, applying Eosin Y as photocata...
Scheme 49: Visible-light-accelerated C–H-sulfinylation of arenes and heteroarenes.
Scheme 50: Visible-light photoredox-catalyzed β-selenosulfonylation of electron-rich olefins, applying [Ru(bpy)...
Scheme 51: Photocatalyzed preparation of β-chlorosulfones from the respective olefins and p-toluenesulfonyl ch...
Scheme 52: a) Photocatalyzed preparation of β-amidovinyl sulfones from sulfonyl chlorides. b) Preparation of β...
Scheme 53: Visible-light photocatalyzed sulfonylation of aliphatic tertiary amines, applying [Ru(bpy)3](PF6)2 ...
Scheme 54: Reiser’s visible-light photoredox-catalyzed preparation of β-hydroxysulfones from sulfonyl chloride...
Scheme 55: a) Sun’s visible-light-catalyzed approach for the preparation of isoquinolinonediones, applying [fac...
Scheme 56: Visible-light photocatalyzed sulfonylation/cyclization of vinyl azides, applying [Ru(bpy)3]Cl2 as p...
Scheme 57: Visible-light photocatalyzed procedure for the formation of β-ketosulfones from aryl sulfonyl chlor...
Scheme 58: Zheng’s method for the sulfenylation of indole derivatives, applying sulfonyl chlorides via visible...
Scheme 59: Cai’s visible-light induced synthesis of β-ketosulfones from sulfonyl hydrazines and alkynes.
Scheme 60: Photoredox-catalyzed approach for the preparation of vinyl sulfones from sulfonyl hydrazines and ci...
Scheme 61: Jacobi von Wangelin’s visible-light photocatalyzed chlorosulfonylation of anilines.
Scheme 62: Three-component photoredox-catalyzed synthesis of N-amino sulfonamides, applying PDI as organic dye....
Scheme 63: Visible-light induced preparation of complex sulfones from oximes, silyl enol ethers and SO2.
Beilstein J. Org. Chem. 2018, 14, 11–24, doi:10.3762/bjoc.14.2
Graphical Abstract
Figure 1: The three major methods for the synthesis of GAuNPs. (a) Direct reduction of an Au3+ salt in the pr...
Scheme 1: The non-catalysed azide–alkyne Huisgen cycloaddition (NCAAC) between an organic azide (1,3-dipole) ...
Scheme 2: Ligand exchange and NCAAC on an AuNP surface. Reagents and conditions: (a) Br(CH2)11SH in DCM, 60 h...
Scheme 3: Azide functionalization and NCAAC on an AuNP surface using electron deficient alkynes. Reagents and...
Scheme 4: NCAAC performed under hyperbaric conditions. Reagents and conditions: (a) Br(CH2)11SH in C6H6, 48 h...
Scheme 5: The synthesis of AuNPs functionalized with strained alkyne derivatives. HBTU = O-benzotriazole-N,N,N...
Scheme 6: A schematic representation of the SPAAC between azide-functionalized polymersomes and strained alky...
Scheme 7: Functionalization of AuNPs with an azide containing thiol ligand, and subsequent attachment to an a...
Scheme 8: Surface modification of AuNPs using microwave-assisted CuAAC. Reagents and conditions: (a) HS(CH2)11...
Scheme 9: AuNP functionalization and efficient CuAAC with a range of alkynes reported by Boisselier et al. [62]. ...
Scheme 10: Schematic illustration of: (a) AuNP deposition on a carbon electrode; (b) formation of alkyne-termi...
Scheme 11: (a) Synthesis of the alkyne-terminated thiol (ATT) ligand 33; (b) synthesis of 12 nm sized ATT-AuNP...
Scheme 12: Synthesis of (a) cyclooctyne-functionalized AuNPs and (b) GAuNPs using SPAAC [82].